LAUSR

The Sf9 cell line, originally isolated from the insect Spodoptera frugiperda, is commonly used alongside the baculovirus expression vector system (BEVS) to produce recombinant proteins and other biologics. As more BEVS‐derived vaccines and therapeutics are approved by regulators and manufactured at scale, there is increasing interest in improving the Sf9 cell line to improve bioprocess robustness and increase product yields. CRISPR‐Cas9 is a powerful genome‐editing tool with great potential to improve cell line characteristics. Nevertheless, reports of genome‐editing in Sf9 cells are scarce, and targets for engineering are elusive. To evaluate the effectiveness of CRISPR‐Cas9 to improve BEVS yields, we generated Sf9 cell lines with functional knockouts in the Sf‐Caspase‐1 gene, which encodes an effector caspase involved in the execution of apoptosis. Deletion of Sf‐Caspase‐1 abolished the hallmarks of apoptotic cell death including plasma membrane blebbing and effector caspase activity. Following infection of Sf‐Caspase‐1 knockout Sf9 cultures with a recombinant baculovirus expressing β‐galactosidase, we did not observe any differences in cell death kinetics or increases in productivity. Similar results were obtained when Sf‐Caspase‐1 expression was suppressed via RNA interference. We anticipate that the CRISPR‐Cas9 workflow reported here will spur future efforts to rationally engineer Sf9 cells for improved baculovirus expression.